Conditions: Dermatitis, Atopic
Keywords: Atopic Dermatitis Atopic Eczema Eczema topical treatment skin diseases tofacitinib CP-690 550 Janus Kinase inhibitor
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 69
Healthy volunteers: no

Brief summary:
The study is being conducted to evaluate the efficacy, safety and tolerability of 2% tofacitinib ointment (20 mg/g) BID (twice daily) in subjects with mild to moderate atopic dermatitis compared to placebo (vehicle) BID for 4 weeks.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Tofacitinib ointment 20mg/g intervention 2: Placebo ointment (Vehicle)
Intervention descriptions: intervention 1: Tofacitinib ointment 20mg/g twice daily (BID) for 4 weeks intervention 2: Placebo ointment (vehicle) twice daily (BID) for 4 weeks

Protocol document: